In a strategic move to tackle Africa’s long-standing reliance on imported medicines, The Alternative Bank has launched a specialized non-interest financing initiative aimed at revitalizing local pharmaceutical manufacturing. This effort targets industrial pharmacists and healthcare providers across Nigeria, offering a lifeline to a sector that has struggled with the high costs of conventional credit.
The urgency of this intervention is underscored by a sobering reality: while Africa carries roughly 25 percent of the global disease burden, it still imports nearly 97 percent of its pharmaceutical needs. This precarious dependence was laid bare during the COVID-19 pandemic, prompting a renewed focus on what experts call “medicine sovereignty.”
During a recent conversation with the National Association of Industrial Pharmacists of Nigeria (NAIP) for their Pharma Industry Digest, Jekwu Ozoemene emphasized that bolstering local production is no longer just an option—it is essential for Nigeria’s economic and healthcare survival. He explained that the bank is positioning itself as a core partner for the entire value chain, using asset-backed and risk-sharing models that prioritize growth over aggressive debt collection.
The bank’s approach differs significantly from traditional lending. By aligning repayment schedules with the actual cash flow of a business, the bank eases the financial strain on manufacturers and distributors. This flexibility allows businesses to focus on expansion rather than the immediate pressure of rigid interest payments.
The suite of products being rolled out nationwide includes stock financing, supply chain support, and revolving drug funds. Beyond just providing capital, the bank is also collaborating with State Health Boards to support broader reforms. These include health insurance schemes and advanced management information systems designed to modernize the industry.
Ozoemene noted that the ultimate goal is to move beyond simply financing importers. The bank is specifically looking to empower industrial pharmacists who are building manufacturing plants that meet World Health Organization standards. By doing so, they hope to ensure that essential medicines are produced right here in Nigeria, securing the nation’s health and future.
